R&D | November 07, 2025
The discussions come as part of the administration’s broader efforts to drive down drug prices and increase patient access to essential therapies
The device delivers clear, high-quality images to support accurate diagnoses across a broad range of patient groups
Adjusted EBITDA increased by 12.3 per cent to $531 million, up from $516 million in the same period last year
The company plans to use the funds to enhance its technology and forge new strategic partnerships with surgical robotics companies
Collaboration aims to deliver rapid, lab-quality testing to communities worldwide – making precision health more accessible
Exemestane is a key therapeutic used in the treatment of certain types of breast cancer in postmenopausal women
Bayer remains a key partner in Ginkgo Bioworks’ growing agricultural biologicals platform
RedHill has obtained a court-approved asset attachment in South Korea to prevent Kukbo from transferring or disposing of assets ahead of enforcement of the judgment
Subscribe To Our Newsletter & Stay Updated
